Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer (AEGC).

Annette Van Zweeden,Cees J. van Groeningen,Richard J. Honeywell,Rita Ruijter,Carolien H. Smorenburg,Giuseppe Giaccone,Henk M.W. Verheul,Godefridus J. Peters,Hans J. van der Vliet

Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer (AEGC).

2016

Annette Van Zweeden
Cees J. van Groeningen
Richard J. Honeywell
Rita Ruijter
Carolien H. Smorenburg
Giuseppe Giaccone
Henk M.W. Verheul
Godefridus J. Peters
Hans J. van der Vliet

e15555Background: The overall prognosis of patients with AECG is poor. Research suggests enhanced efficacy and reduced toxicity of cisplatin due to folic acid and vitamin B12 suppletion. In this ra...

Keywords:

Cancer
Phases of clinical research
Oncology
Cisplatin
Gemcitabine
Pathology
Vitamin supplementation
Internal medicine
Medicine
folic acid
esophagogastric cancer
Gastroenterology
in patient
Vitamin B12

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations